These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29607699)

  • 1. Synergic highly effective photothermal-chemotherapy with platinum prodrug linked melanin-like nanoparticles.
    Zhang C; Zhao X; Guo H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):356-363. PubMed ID: 29607699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turning Ineffective Transplatin into a Highly Potent Anticancer Drug via a Prodrug Strategy for Drug Delivery and Inhibiting Cisplatin Drug Resistance.
    Li W; Jiang M; Cao Y; Yan L; Qi R; Li Y; Jing X
    Bioconjug Chem; 2016 Aug; 27(8):1802-6. PubMed ID: 27380489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles of metal-organic cages designed to encapsulate platinum-based anticancer agents.
    Yue Z; Wang H; Bowers DJ; Gao M; Stilgenbauer M; Nielsen F; Shelley JT; Zheng YR
    Dalton Trans; 2018 Jan; 47(3):670-674. PubMed ID: 29257160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
    Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
    Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
    Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
    Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR
    Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z
    Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of Platinum(IV) Prodrugs via Bi
    Ma Y; Zhang DY; Peng Z; Guan S; Zhai J
    Mol Pharm; 2020 Sep; 17(9):3403-3411. PubMed ID: 32692573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrosion-Activated Chemotherapeutic Function of Nanoparticulate Platinum as a Cisplatin Resistance-Overcoming Prodrug with Limited Autophagy Induction.
    Cheng HJ; Wu TH; Chien CT; Tu HW; Cha TS; Lin SY
    Small; 2016 Nov; 12(44):6124-6133. PubMed ID: 27717137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.
    Yu C; Ding B; Zhang X; Deng X; Deng K; Cheng Z; Xing B; Jin D; Ma P; Lin J
    Biomaterials; 2018 Feb; 155():112-123. PubMed ID: 29175080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
    Kang X; Wang Y; Chen Z; Wu Y; Chen H; Yang X; Yu C
    Chem Commun (Camb); 2020 Sep; 56(76):11271-11274. PubMed ID: 32830841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy.
    Yu J; Zhang X; Pei Z; Shuai Q
    J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-mediated delivery of multinuclear platinum(IV) prodrugs with enhanced drug uptake and the activity of overcoming drug resistance.
    Gao Y; Jiang M; Ma Y; Wu S; Li W; Yang X; Li Y; Jing X; Jiang H
    Anticancer Drugs; 2016 Feb; 27(2):77-83. PubMed ID: 26473527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H; Cheng Q; Yuan S; Ding X; Liu Y
    Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermal-chemotherapy.
    Zhang Y; Yang D; Chen H; Lim WQ; Phua FSZ; An G; Yang P; Zhao Y
    Biomaterials; 2018 May; 163():14-24. PubMed ID: 29452945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly effective photothermal chemotherapy with pH-responsive polymer-coated drug-loaded melanin-like nanoparticles.
    Zhang C; Zhao X; Guo S; Lin T; Guo H
    Int J Nanomedicine; 2017; 12():1827-1840. PubMed ID: 28331308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment.
    Wang Z; Deng Z; Zhu G
    Dalton Trans; 2019 Feb; 48(8):2536-2544. PubMed ID: 30633263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-responsive photothermal-chemotherapy with drug-loaded melanin-like nanoparticles for synergetic tumor ablation.
    Wang X; Zhang J; Wang Y; Wang C; Xiao J; Zhang Q; Cheng Y
    Biomaterials; 2016 Mar; 81():114-124. PubMed ID: 26731575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug.
    Shanmugam V; Chien YH; Cheng YS; Liu TY; Huang CC; Su CH; Chen YS; Kumar U; Hsu HF; Yeh CS
    ACS Appl Mater Interfaces; 2014 Mar; 6(6):4382-93. PubMed ID: 24559392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.